130 related articles for article (PubMed ID: 28362175)
1. Synergistic Impact of d-δ-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 Prostate Carcinoma Cells.
Yeganehjoo H; DeBose-Boyd R; McFarlin BK; Mo H
Nutr Cancer; 2017; 69(4):682-691. PubMed ID: 28362175
[TBL] [Abstract][Full Text] [Related]
2. Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase.
Fernandes NV; Yeganehjoo H; Katuru R; DeBose-Boyd RA; Morris LL; Michon R; Yu ZL; Mo H
Exp Biol Med (Maywood); 2013 Nov; 238(11):1265-74. PubMed ID: 24006306
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Impact of Xanthorrhizol and
Chan D; Meister ML; Madhani CR; Elfakhani M; Yount ST; Ji X; Feresin RG; Wanders D; Mo H
Nutr Cancer; 2021; 73(9):1746-1757. PubMed ID: 32811212
[TBL] [Abstract][Full Text] [Related]
4. β-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells.
Jones S; Fernandes NV; Yeganehjoo H; Katuru R; Qu H; Yu Z; Mo H
Nutr Cancer; 2013; 65(4):600-10. PubMed ID: 23659452
[TBL] [Abstract][Full Text] [Related]
5. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
6. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
7. Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells.
Katuru R; Fernandes NV; Elfakhani M; Dutta D; Mills N; Hynds DL; King C; Mo H
Exp Biol Med (Maywood); 2011 May; 236(5):604-13. PubMed ID: 21540247
[TBL] [Abstract][Full Text] [Related]
8. d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells.
Fernandes NV; Guntipalli PK; Mo H
Anticancer Res; 2010 Dec; 30(12):4937-44. PubMed ID: 21187473
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes.
Torabi S; Yeganehjoo H; Shen CL; Mo H
Nutr Res; 2016 Dec; 36(12):1345-1352. PubMed ID: 27884413
[TBL] [Abstract][Full Text] [Related]
10. The stimulatory impact of d-δ-Tocotrienol on the differentiation of murine MC3T3-E1 preosteoblasts.
Shah AK; Yeganehjoo H
Mol Cell Biochem; 2019 Dec; 462(1-2):173-183. PubMed ID: 31620952
[TBL] [Abstract][Full Text] [Related]
11. d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.
Hussein D; Mo H
Pancreas; 2009 May; 38(4):e124-36. PubMed ID: 19346993
[TBL] [Abstract][Full Text] [Related]
12. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
[TBL] [Abstract][Full Text] [Related]
13. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.
Elson CE; Peffley DM; Hentosh P; Mo H
Proc Soc Exp Biol Med; 1999 Sep; 221(4):294-311. PubMed ID: 10460692
[TBL] [Abstract][Full Text] [Related]
14. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
Sivaprasad U; Abbas T; Dutta A
Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
[TBL] [Abstract][Full Text] [Related]
15. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
Duncan RE; Lau D; El-Sohemy A; Archer MC
Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
[TBL] [Abstract][Full Text] [Related]
16. Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.
Wali VB; Bachawal SV; Sylvester PW
Lipids; 2009 Oct; 44(10):925-34. PubMed ID: 19777282
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
19. Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens.
Qureshi AA; Pearce BC; Nor RM; Gapor A; Peterson DM; Elson CE
J Nutr; 1996 Feb; 126(2):389-94. PubMed ID: 8632210
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of delta-tocotrienol, a HMG CoA reductase inhibitor, on monocyte-endothelial cell adhesion.
Chao JT; Gapor A; Theriault A
J Nutr Sci Vitaminol (Tokyo); 2002 Oct; 48(5):332-7. PubMed ID: 12656204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
